dipyridamole has been researched along with Frostbite in 1 studies
Dipyridamole: A phosphodiesterase inhibitor that blocks uptake and metabolism of adenosine by erythrocytes and vascular endothelial cells. Dipyridamole also potentiates the antiaggregating action of prostacyclin. (From AMA Drug Evaluations Annual, 1994, p752)
dipyridamole : A pyrimidopyrimidine that is 2,2',2'',2'''-(pyrimido[5,4-d]pyrimidine-2,6-diyldinitrilo)tetraethanol substituted by piperidin-1-yl groups at positions 4 and 8 respectively. A vasodilator agent, it inhibits the formation of blood clots.
Frostbite: Damage to tissues as the result of low environmental temperatures.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Da Costa, J | 1 |
| Sharp, FR | 1 |
| Gill, W | 1 |
1 other study available for dipyridamole and Frostbite
| Article | Year |
|---|---|
The effect of dipyridamole on tissue perfusion following freezing injury in the rat.
Topics: Animals; Blood Platelets; Capillary Permeability; Dipyridamole; Freezing; Frostbite; Rats; Regional | 1971 |